|
MTO1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.48269999999495E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.155900E-04 |
| Normal-vs-Stage2 |
2.361900E-02 |
| Normal-vs-Stage3 |
1.27569999996968E-06 |
| Normal-vs-Stage4 |
1.43890000003921E-06 |
| Stage1-vs-Stage2 |
6.193400E-01 |
| Stage1-vs-Stage3 |
4.312000E-02 |
| Stage1-vs-Stage4 |
7.610100E-02 |
| Stage2-vs-Stage3 |
8.262000E-02 |
| Stage2-vs-Stage4 |
8.605500E-02 |
| Stage3-vs-Stage4 |
8.469000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.24920000002626E-06 |
| Normal-vs-AfricanAmerican |
2.369600E-02 |
| Normal-vs-Asian |
8.958300E-03 |
| Caucasian-vs-AfricanAmerican |
3.957400E-01 |
| Caucasian-vs-Asian |
3.205800E-01 |
| AfricanAmerican-vs-Asian |
9.417600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.64589999998677E-06 |
| Normal-vs-Female |
1.416540E-04 |
| Male-vs-Female |
1.348420E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.836700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.8086099999981E-05 |
| Normal-vs-Age(61-80Yrs) |
1.95849999995446E-06 |
| Normal-vs-Age(81-100Yrs) |
5.201900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.356800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.161360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.164800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.728000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.848800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.108400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.044300E-02 |
| Classical-VS-Follicular |
1.589420E-01 |
| Classical-VS-Other |
1.962180E-01 |
| Classical-VS-Normal |
3.961700E-04 |
| Tall-VS-Follicular |
3.631200E-01 |
| Tall-VS-Other |
8.522200E-01 |
| Tall-VS-Normal |
1.6422199999977E-05 |
| Follicular-VS-Other |
5.968800E-01 |
| Follicular-VS-Normal |
1.211710E-04 |
| Other-VS-Normal |
6.144400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.30639999999616E-05 |
| Normal-vs-N1 |
2.02760000000968E-06 |
| N0-vs-N1 |
1.401220E-01 |
|
|
